Published: May 15th 2024 | Updated: May 20th 2024
Minimizing the carbon footprint of ophthalmic surgeries
Published: October 24th 2024 | Updated: November 6th 2024
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
Published: October 23rd 2024 | Updated: November 6th 2024
The top 10 takeaways from AAO 2024
Published: October 31st 2024 | Updated: November 6th 2024
Intense pulsed light for treatment of dry eye disease
Published: October 24th 2024 | Updated: November 6th 2024
EyePoint Pharmaceuticals announces first patient dosed in global Phase 3 LUGANO clinical trial of Duravyu for wet AMD
Published: October 28th 2024 | Updated: November 6th 2024
EyePoint Pharmaceuticals announces positive interim 16-Week data for ongoing Phase 2 VERONA clinical trial of Duravyu for DME